Mr. Collis brings extensive CEO, healthcare industry, and regulatory and public policy experience to the Board gained through his position as Chairman, President and Chief Executive Officer of a large, global pharmaceutical solutions company, which is subject to significant regulation and oversight. In addition, Mr. Collis has finance and capital markets experience through his former positions as the CEO of a public company, the CFO of a private company, and a chartered accountant. Mr. Collis qualifies as an "audit committee financial expert." Professional and Other Experience: Cencora, Inc. (formerly AmerisourceBergen Corporation) ("Cencora"), a pharmaceutical solutions company, Executive Chairman (2024-2025), Chairman, President and Chief Executive Officer (2016-2024) and President and Chief Executive Officer (2011-2016) Cencora, various other management positions (1994-2011) American Red Cross, Board of Governors (2018-2025) International Federation of Pharmaceutical Wholesalers, Director (2011-2025) Other Public Board Service: Bausch & Lomb Corporation, an eye health products company, Director (since January 2026) Cencora, Director (2011-2025), Chairman of the Board (2016-2024), Executive Chairman (2024-2025) Thoratec Corporation, a medical device developer and manufacturer, Director (2008-2015) Age: 64 Director Since: 2025 Committees: Audit Finance Skills, Experiences and Attributes: CEO COO/Executive Leadership Finance/Capital Markets Healthcare Industry Regulatory/Public Policy Education: B. Commerce, Post-Grad; B. Commerce and Chartered Accountant, University of the Witwatersrand, Johannesburg